Clínica Dermacross S.A. - Vitacura - Santiago
Clínica Dermacross nace el 2010 para proporcionar, en un ambiente privado, tratamientos específicos y de vanguardia para sus pacientes. Nuestro foco central es en la atención humana e integral, siendo un gran aporte en el avance científico de la investigación clínica. En nuestros inicios fuimos un centro de investigación para psoriasis y rápidamente fuimos ampliándonos al área de la Dermatología, Reumatología y actualmente incorporamos 2 nuevas áreas terapéuticas: Cardiología y Gastroenterología, para poder ser un centro modelo en la investigación clínica El equipo médico está formado por reconocidos especialistas de sus áreas, de las mejores universidades del país y cuenta con una nuestra infraestructura de primer nivel, con todas las aprobaciones del SEREMI e ISPAv. Manquehue Norte 2051 C, Vitacura, Metropolitana, 7640881
Websitehttp://dermacross.cl
Select an option
I am a doctor
I am a sponsor
Specializations
Dermatología
Venerología
Psoriasis
Our team
Medical staff
Jaime del Río
Claudia Paz De la Cruz Fernández
Lilian Soto
Paula Calderon
Julian Vega
Elizabeth Molina
Tatiana del Rio
Matias Silva
Claudia Rojas
Open studies
Crohn's disease
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease. - Risa CD SubQ - AbbVieSee more
Dermatitis
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor - AQUA - SanofiSee more
Hidradenitis suppurativa
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy - Step-Up HS - AbbVieSee more
Interstitial Lung Disease
Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) - ATHENA-SSc-ILD - Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)See more
Lupus
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST) - AMETHYST - BiogenSee more
Rare diseases
Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) - ATHENA-SSc-ILD - Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)See more
Urticaria
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) - EMBARQ-CSU2 - Celldex TherapeuticsSee more
